Kenvue: An Intriguing Turnaround

Core Insights - Kenvue, the former consumer health business of Johnson & Johnson, has underperformed since its IPO 21 months ago, leading to a reduction in guidance for both 2023 and 2024 [1] Company Performance - Kenvue has cut its financial guidance for the upcoming years, indicating ongoing challenges in its business operations [1] Market Context - The company was spun off from Johnson & Johnson and has struggled to meet market expectations since going public [1]